Early rescue of interneuron disease trajectory in developmental epilepsies
Meagan S Siehr1, Jeffrey L Noebels2
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.
Abstract:
The discovery of over 150 monogenic epilepsies and advances in early genetic diagnoses have launched a search for molecular strategies and developmental timetables to reverse or even prevent the course of these debilitating brain disorders. Orthologous rodent models of key disease genes are providing important examples of the range of targets, and serve as valuable test systems for perinatal therapeutic approaches. While gene-specific analyses of single rare 'orphan' diseases are each narrow in scope, they illuminate downstream pathways converging onto interneurons, and treatments that strengthen inhibition during cortical maturation may provide broad protection against these seemingly disparate gene errors. Several genes, even those linked to malformations, show promise for postnatal correction before the onset of their clinical phenotype.
Insights
Advances in diagnosing monogenic epilepsies drive research into molecular strategies and developmental timetables for prevention. Rodent models and interneuron-targeted therapies show promise for treating these debilitating brain disorders.
Area of Science:
- Neuroscience
- Genetics
- Developmental Biology
Background:
- Over 150 monogenic epilepsies identified, with advances in early genetic diagnosis.
- Need for molecular strategies and developmental timetables to reverse or prevent epilepsy progression.
- Rare 'orphan' epilepsies offer insights into downstream pathways affecting interneurons.
Purpose of the Study:
- To explore molecular strategies for reversing or preventing monogenic epilepsies.
- To investigate the potential of perinatal therapeutic approaches using rodent models.
- To identify broad protective treatments targeting cortical maturation and interneuron function.
Main Methods:
- Utilizing orthologous rodent models of key epilepsy-related genes.
- Analyzing gene-specific pathways in rare monogenic epilepsies.
- Investigating downstream pathways converging onto interneurons.
Main Results:
- Rodent models serve as test systems for perinatal therapeutic strategies.
- Gene-specific analyses reveal converging pathways onto interneurons.
- Treatments strengthening inhibition during cortical maturation may offer broad protection.
- Postnatal correction shows promise for certain genes, even those linked to malformations.
Conclusions:
- Targeting interneuron pathways and cortical maturation may provide broad protection against diverse monogenic epilepsies.
- Early intervention and postnatal correction strategies hold promise for preventing or reversing epilepsy phenotypes.
- Further research into molecular and developmental strategies is crucial for combating these brain disorders.
